Global Longlife Hospital re-appoints Manasvi Manu Thapar as Independent Director
Global Longlife Hospital and Research Limited re-appointed Mr. Manasvi Manu Thapar as Independent Director for a second term of five years from September 10, 2026, to September 09, 2031, following shareholder approval at the AGM on June 25, 2026. All seven resolutions, including the re-appointment of Mr. Dhruv Jani as Managing Director and other key approvals, passed with 100% votes in favour.

*this image is generated using AI for illustrative purposes only.
Global Longlife Hospital and Research Limited re-appointed Mr. Manasvi Manu Thapar as Independent Director for a second term of five years, commencing from September 10, 2026, to September 09, 2031, following shareholder approval at its 15th Annual General Meeting (AGM) on June 25, 2026. The AGM, which commenced at 11:00 A.M. and concluded at 11:08 A.M., saw the re-appointment approved based on the Board of Directors' recommendation. Mr. Thapar is a legal professional with 10 years of experience and operates his own practice under the firm name Candour Legal.
Voting Results and Key Resolutions
Shareholders approved all seven resolutions through remote e-voting, with 36,88,990 votes cast in favour of every proposal, representing 100% of the total valid votes polled. The scrutinizer's report confirmed the requisite majority for all resolutions. No votes were cast during the physical AGM, as voting was conducted solely via remote e-voting from June 22, 2026, to June 24, 2026. The total number of shareholders on the record date of May 30, 2026, was 1158.
| Sr. No | Resolution Description | Type | Votes In Favour | % of Votes |
|---|---|---|---|---|
| 1 | Adoption of Audited Financial Statements for FY26 | Ordinary Resolution | 36,88,990 | 100% |
| 2 | Re-appointment of Ms. Sucheta Jani (DIN: 06502321) | Ordinary Resolution | 36,88,990 | 100% |
| 3 | Appointment of Mr. Hiren Mandaliya (DIN: 11636452) as Independent Director | Special Resolution | 36,88,990 | 100% |
| 4 | Approval of Change in Name of the Company | Special Resolution | 36,88,990 | 100% |
| 5 | Alteration of Object clause of MOA | Special Resolution | 36,88,990 | 100% |
| 6 | Re-appointment of Mr. Dhruv Jani (DIN: 03154680) as Managing Director | Special Resolution | 36,88,990 | 100% |
| 7 | Re-appointment of Mr. Manasvi Manu Thapar (DIN: 07486932) as Independent Director | Special Resolution | 36,88,990 | 100% |
Meeting and Compliance Details
The meeting was chaired by Mr. Dhruv Jani, Managing Director. Ms. Insiya Nalawala, Practicing Company Secretary, served as the scrutinizer for the e-voting process, with results witnessed by Mr. Mustansir Bhopali and Mr. Moiz Ezzi. Promoters and promoter groups held 24,01,990 shares, while public non-institutions held 80,98,010 shares. The statutory auditors, M/s. R.B. Gohil & Co., reported no qualifications on the financial transactions. The disclosure was made to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Global Longlife Hospital & Research
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.86% | +15.56% | -4.56% | -49.39% | -52.48% | -91.66% |
What strategic rationale drove the approval to change the company's name and alter its object clause?
How will the re-appointment of the Managing Director and new Independent Directors influence the company's long-term strategic direction?
What specific new business areas will the company pursue following the alteration of the Memorandum of Association's object clause?































